Innovative Partnership: AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC Platform

MUMBAI, India and SPOKANE, Wash., March 24, 2025 /PRNewswire/ — AIRA Matrix, a leading innovator in AI-driven QC solutions, and Gestalt, an industry leader in IMS and digital pathology, have formed a strategic partnership to bring AIRA Matrix’s advanced AI solution, AIRAQC, to Gestalt’s PathFlow. This collaboration marks a significant step toward enhancing diagnostic precision and efficiency in laboratories worldwide.

AIRAQC, powered by cutting-edge artificial intelligence, streamlines quality control processes, enabling faster and more accurate analysis in pathology workflows. By integrating AIRAQC with Gestalt’s workflows, pathologists will gain access to a seamless, AI-enhanced experience designed to optimize diagnostic decision-making.

“We’re thrilled to partner with Gestalt to expand the reach of AIRAQC and deliver transformative AI capabilities to pathology labs,” said Marco Comianos, Head of Commercial Operations – US., AIRA Matrix. “This collaboration is a testament to our shared commitment to advancing pathology through innovation.”

“The partnership between AIRA Matrix and Gestalt represents a continued effort to drive progress in pathology by leveraging technology to meet evolving healthcare needs. Together, our companies aim to empower laboratories with state-of-the-art tools that improve diagnostic accuracy, quality and meaningful metrics from the start of the diagnostic process” says Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer.

About AIRA Matrix:
Delivers artificial intelligence solutions for healthcare and life sciences applications. Our innovative products and services drive efficiency, enhance diagnostic accuracy, and provide data-driven insights from digitally scanned images. Our comprehensive AI-driven suite for drug discovery and development, streamlines pre-analytical quality control, facilitates tissue triage, and optimizes safety and efficacy assessments, accelerating breakthrough discoveries. Our healthcare portfolio offers diagnostic, prognostic, and predictive tools that facilitate risk stratification and enable personalized therapy planning, thus improving treatment outcomes., visit www.airamatrix.com.

About Gestalt Diagnostics:
Gestalt transforms pathology through an intelligent, configurable, vendor-neutral, and AI-driven digital workflow that provides true interoperability enabling pathologists to diagnose* diseases faster and more efficiently. Our PathFlow® solution consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks allowing them to focus on their expertise, providing invaluable experience where it matters most.

View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-partnership-aira-matrix-partners-with-gestalt-to-elevate-diagnostics-with-ai-driven-qc-platform-302407056.html

SOURCE Gestalt Diagnostics